Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen

International Immunopharmacology

Volumn 9, Issue 12, 2009, Pages 1411-1422

  Nicolis, Elena ^a   Lampronti, Ilaria ^b   Dechecchi, Maria Cristina ^a   Borgatti, Monica ^b   Tamanini, Anna ^a   Bezzerri, Valentino ^a   Bianchi, Nicoletta ^b   Mazzon, Martina ^a   Mancini, Irene ^b   Giri, Maria Grazia ^a   Rizzotti, Paolo ^a   Gambari, Roberto ^b   Cabrini, Giulio ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b ER GenTech   (Italy)

Author keywords

Cystic fibrosis; Cytokine; Inflammation; Pseudomonas aeruginosa; Psoralen

Indexed keywords

AEGLE MARMELOS EXTRACT; APHANAMIXIS POLYSTACHYA EXTRACT; ARGEMONE OIL; BERGAPTEN; HEMIDESMUS INDICUS EXTRACT; INTERLEUKIN 8; LAGERSTROEMIA SPECIOSA EXTRACT; MESSENGER RNA; PLANT EXTRACT; POLYALTHIA LONGIFOLIA EXTRACT; UNCLASSIFIED DRUG; VERNONIA ANTHELMINTICA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CELL PROLIFERATION; CYSTIC FIBROSIS; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ARGEMONE; BRONCHI; CELL LINE; CELL PROLIFERATION; CYSTIC FIBROSIS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; METHOXSALEN; NEUTROPHILS; PHOTOSENSITIZING AGENTS; PLANT EXTRACTS; PSEUDOMONAS AERUGINOSA; VERNONIA;

EID: 70349414269     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.08.013     Document Type: Article

References (47)

1. Khan T.Z., Wagener J.S., Bost T., Martinez J., Accurso F.J., and Riches D.W. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151 (1995) 1075-1082
2. Noah T.L., Black H.R., Cheng P.W., Wood R.E., and Leigh M.W. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis 175 (1997) 638-647
3. DiMango E., Ratner A.J., Bryan R., Tabibi S., and Prince A. Activation of NF-kB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 101 (1998) 2598-2605
4. Puchelle E., De Bentzmann S., Hubeau C., Jacquot J., and Gaillard D. Mechanisms involved in cystic fibrosis airway inflammation. Pediatr Pulmonol S23 (2001) 143-145
5. Joseph T., Look D., and Ferkol T. NF-kB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 288 (2005) L471-L479
6. Meusser B., Hirsch C., Jarosch E., and Sommer T. ERAD: the long road to destruction. Nat Cell Biol 7 (2005) 766-772
7. Vij N., Fang S., and Zeitlin P.L. Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications. J Biol Chem 281 (2006) 17369-17378
8. Bartling T.R., and Drumm M.L. Oxidative stress causes IL8 promoter hyperacetylation in cystic fibrosis airway cell models. Am J Respir Cell Mol Biol 40 (2009) 58-65
9. Döring G., and Worlitzsch D. Inflammation in cystic fibrosis and its management. Paediatr Respir Rev 1 (2000) 101-106
10. Koehler D.R., Downey G.P., Sweezey N.B., Tanswell A.K., and Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 31 (2004) 377-381
11. Griesenbach U., Geddes D.M., and Alton E.W. Gene therapy progress and prospects: cystic fibrosis. Gene Ther 13 (2006) 1061-1067
12. Wilschanski M., Yahav Y., Yaacov Y., Blau H., Bentur L., Rivlin J., et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med 349 (2003) 1433-1441
13. Du M., Liu X., Welch E.M., Hirawat S., Peltz S.W., and Bedwell D.M. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci U S A 105 (2008) 2064-2069
14. Kerem E., Hirawat S., Armoni S., Yaakov Y., Shoseyov D., Cohen M., et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 372 (2008) 719-727
15. MacDonald K.D., McKenzie K.R., and Zeitlin P.L. Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation. Paediatr Drugs 9 (2007) 1-10
16. Ratjen F. What's new in CF airway inflammation: an update. Paediatr Respir Rev 7 Suppl 1 (2006) S70-S72
17. Rubin B.K. CFTR is a modulator of airway inflammation. Am J Physiol Lung Cell Mol Physiol 292 (2007) L381-L382
18. Konstan M.W., Doring G., Lands L.C., Hilliard K.A., Koker P., Bhattacharya S., et al. Results of a phase II clinical trial of BIIL284 BS for the treatment of CF lung disease. Pediatr Pulmonol S 28 (2005) 125-126
19. Kawai T., and Akira S. TLR signaling. Cell Death Differ 13 (2006) 816-825
20. Hoffmann E., Dittrich-Breiholz O., Holtmann H., and Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 72 (2002) 847-855
21. Koehn F.E., and Carter G.T. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4 (2005) 206-220
22. Akesson C., Lindgren H., Pero R.W., Leanderson T., and Ivars F. An extract of Uncaria tomentosa inhibiting cell division and NF-kappa B activity without inducing cell death. Int Immunopharmacol 3 (2003) 1889-1900
23. Hwang B.Y., Lee J.H., Koo T.H., Kim H.S., Hong Y.S., Ro J.S., et al. Kaurane diterpenes from Isodon japonicus inhibit nitric oxide and prostaglandin E2 production and NF-kappaB activation in LPS-stimulated macrophage RAW264.7 cells. Planta Med 67 (2001) 406-410
24. Lee J.H., Ko W.S., Kim Y.H., Kang H.S., Kim H.D., and Choi B.T. Anti-inflammatory effect of the aqueous extract from Lonicera japonica flower is related to inhibition of NF-kappaB activation through reducing I-kappaBalpha degradation in rat liver. Int J Mol Med 7 (2001) 79-83
25. Zeitlin P.L., Lu L., Rhim J., Cutting G., Stetten G., Kieffer K.A., et al. A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection. Am J Respir Cell Mol Biol 14 (1991) 313-319
26. Dechecchi M.C., Nicolis E., Bezzerri V., Vella A., Colombatti M., Assael B.M., et al. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells. Am J Respir Cell Mol Biol 36 (2007) 615-624
27. Khan M.T.H., Lampronti I., Martello D., Bianchi N., Jabbar S., Choudhuri M.S.K., et al. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: effects on in vitro cell growth of human tumor cell lines. Int J Onc 20 (2002) 187-192
28. Tomkins B.A., and Sega G.A. Determination of thiodyglycol in groundwater using solid-phase extraction followed by gas chromatography with mass spectrometric detection in the selected-ion mode. J Chromatogr 909 (2001) 13-28
29. Nicolis E., Lampronti I., Dechecchi M.C., Borgatti M., Tamanini A., Bianchi N., et al. Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells. Int Immunopharmacol 10 (2008) 1672-1680
30. Jaffe A., and Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol 31 (2001) 464-473
31. Ribeiro C.M.P., Hurd H., Wu Y., Martino M.E.B., Jones L., Brighton B., et al. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PLoS One 4 (2009) e5806
32. Schmidt B.M., Ribnicky D.M., Lipsky P.E., and Raskin I. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 3 (2007) 360-366
33. Lambertini E., Piva R., Khan M.T., Lampronti I., Bianchi N., Borgatti M., et al. Effects of extracts from Bangladeshi medicinal plants on in vitro proliferation of human breast cancer cell lines and expression of estrogen receptor alpha gene. Int J Oncol 24 (2004) 419-423
34. Lampronti I., Khan M.T., Bianchi N., Ather A., Borgatti M., Vizziello L., et al. Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites. Med Chem 1 (2005) 327-333
35. Lampronti I., Khan M.T., Borgatti M., Bianchi N., and Gambari R. Inhibitory effects of Bangladeshi medicinal plant extracts on interactions between transcription factors and target DNA sequences. Evid Based Complement Alternat Med 5 (2008) 303-312
36. Haadsma-Svensson S.R., Cleek K.A., Dinh D.M., Duncan J.N., Haber C.L., Huff R.M., et al. Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5, 6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans. J Med Chem 44 (2001) 4716-4732
37. Sheng R., Xu Y., Hu C., Zhang J., Lin X., Li J., et al. Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives. Eur J Med Chem 44 (2009) 772-784
38. Camps P., Formosa X., Galdeano C., Gómez T., Muñoz-Torrero D., Scarpellini M., et al. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. J Med Chem 51 (2008) 3588-3598
39. Saxena H.O., Faridi U., Kumar J.K., Luqman S., Darokar M.P., Shanker K., et al. Synthesis of chalcone derivatives on steroidal framework and their anticancer activities. Steroids 72 (2007) 892-900
40. Saxena H.O., Faridi U., Srivastava S., Kumar J.K., Darokar M.P., Luqman S., et al. Gallic acid-based indanone derivatives as anticancer agents. Bioorg Med Chem Lett 18 (2008) 3914-3918
41. Menter A., and Griffiths C.E. Current and future management of psoriasis. Lancet 370 (2007) 272-284
42. Kitamura N., Kohtani S., and Nakagaki R. Molecular aspects of furocoumarin reactions: photophysics, photochemistry, photobiology, and structural analysis. J Photochem Photobiol 6 (2007) 168-185
43. Stern R.S. Psoralen and ultraviolet A light therapy for psoriasis. N Engl J Med 357 (2007) 682-690
44. Viola G., Vedaldi D., Dall'Acqua F., Lampronti I., Bianchi N., Zuccato C., et al. Furocoumarins photolysis products induce differentiation of human erythroid cells. J Photochem Photobiol 92 (2008) 24-28
45. Viola G., Vedaldi D., Dall'Acqua F., Fortunato E., Basso G., Bianchi N., et al. Induction of gamma-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocumarin derivatives. Biochem Pharmacol 75 (2008) 810-825
46. Tanew A., Ortel B., Rappersberger K., and Hönigsmann H. 5-Methoxypsoralen (bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation. J Am Acad Dermatol 18 (1988) 333-338
47. Frerichs C., and Smyth A. Treatment strategies for cystic fibrosis: what's in the pipeline?. Expert Opin Pharmacother 10 (2009) 1191-1202